-
Taxonomy & unit
-
ratio: %
-
Description
-
Return on assets can be defined as an indicator of how profitable a company is relative to its total assets. Calculated by dividing a company's operating earnings by its total assets.
-
Summary
-
Adaptimmune Therapeutics PLC quarterly/annual Return On Assets history and growth rate from Q4 2016 to Q3 2024.
- Adaptimmune Therapeutics PLC Return On Assets for the quarter ending September 30, 2024 was -15.1 %, a 50.2% increase year-over-year.
- Adaptimmune Therapeutics PLC annual Return On Assets for 2023 was -37.6 %, a 16.5% increase from 2022.
- Adaptimmune Therapeutics PLC annual Return On Assets for 2022 was -45.1 %, a 15.7% decline from 2021.
- Adaptimmune Therapeutics PLC annual Return On Assets for 2021 was -38.9 %, a 29.2% decline from 2020.
Return On Assets, Quarterly (%)
Return On Assets, YoY Quarterly Growth (%)